Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Exemestane Therapy for Metastatic Breast Cancer

NCT00810797 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00810797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00810797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Exemestane Therapy for Metastatic Breast Cancer
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Completed
Start date
December 2, 2008
Completion date
June 26, 2019
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer